Reyon Pharmaceutical Co. Ltd. | Balance Sheet
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
43,985
49,934
41,442
36,826
83,638
151,183
Total Accounts Receivable
52,794
55,810
56,399
56,952
54,219
52,383
Inventories
23,032
19,393
21,898
21,002
21,689
20,798
Other Current Assets
148
186
90
61
69
58
Total Current Assets
119,959
125,324
119,829
114,842
159,615
224,422
Net Property, Plant & Equipment
18,086
18,817
18,354
18,871
20,701
56,151
Total Investments and Advances
21,579
31,570
103,612
67,985
102,629
15,289
Long-Term Note Receivable
5,173
-
-
-
-
-
Intangible Assets
12,958
14,910
18,647
20,810
21,502
4,539
Other Assets
645
625
486
1,351
1,256
1,521
Total Assets
178,399
191,246
260,929
223,858
305,703
303,167
ST Debt & Current Portion LT Debt
10,360
14,812
2,000
2,000
-
Accounts Payable
3,553
2,941
3,432
2,942
3,470
Income Tax Payable
1,869
2,237
3,300
1,495
2,094
Other Current Liabilities
17,440
9,867
11,747
12,251
9,914
Total Current Liabilities
33,222
29,856
20,479
18,688
15,478
Long-Term Debt
-
-
-
-
34,040
Deferred Taxes
4,783
5,884
22,622
11,752
21,661
Total Liabilities
38,005
35,740
43,101
30,440
71,179
Common Equity (Total)
140,394
155,506
217,828
193,418
234,525
Total Shareholders' Equity
140,394
155,506
217,828
193,418
234,525
Total Equity
140,394
155,506
217,828
193,418
234,525
Liabilities & Shareholders' Equity
178,399
191,246
260,929
223,858
305,703
About Reyon Pharmaceutical Co.
View Profile
